Related Experiment Videos
Production and characterization of genetically engineered antibody molecules
S L Morrison1, S Canfield, S Porter
1Department of Microbiology, Columbia University College of Physicians and Surgeons, New York, NY 10032.
Clinical Chemistry
|September 1, 1988
Summary
Researchers can now engineer monoclonal antibodies with enhanced functions by transfecting cells with antibody genes. This genetic engineering approach allows for improved biological properties and precise antigen binding, paving the way for novel antibody therapeutics.
Area of Science:
- Molecular Biology
- Immunology
- Biotechnology
Background:
- Monoclonal antibodies (mAbs) are crucial for research and therapeutics.
- Improving mAb biological and antigen-binding properties is an ongoing goal.
- Genetic engineering offers a powerful tool for mAb development.
Purpose of the Study:
- To describe a method for producing monoclonal antibodies with improved properties using gene transfection.
- To enable the efficient expression of transfected immunoglobulin genes in eukaryotic cells.
- To facilitate the creation of antibodies with diverse structures, including chimeric antibodies.
Main Methods:
- Placing immunoglobulin heavy- and light-chain genes into vectors with selectable markers.
- Transfecting these vectors into myeloma and hybridoma cells.
- Selecting drug-resistant cells to isolate transfectants expressing the desired antibody genes.
Main Results:
- Efficient expression of transfected immunoglobulin genes was achieved.
- Produced antibodies accurately reflected the introduced genetic material.
- Simultaneous delivery of heavy and light chains using different selectable markers was successful.
Conclusions:
- Gene transfection provides a robust method for producing engineered monoclonal antibodies.
- This technique allows for the generation of antibodies with tailored structures and functions.
- Future applications include developing next-generation antibodies with enhanced antigen binding and effector functions.